John Alexander

Duke University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (16)

Alexander Fanaroff

Assistant Professor of Medicine

University of Pennsylvania

UNITED STATES

View details

Jeffrey Carson

Rutgers, The State Univ. of NJ

UNITED STATES

View details

Yogesh Sharma

Associate Professor

Flinders Medical Centre

AUSTRALIA

View details

Dean Fergusson

Full Professor

University of Ottawa

CANADA

View details

Sana M. Al-Khatib

Duke University School of Medicine

UNITED STATES

View details

Derek Chew

Flinders University

AUSTRALIA

View details

Philippe Gabriel Steg

FRANCE

View details

Maria Brooks

University of Pittsburgh

UNITED STATES

View details

Christopher B Granger

Duke University Medical Center

UNITED STATES

View details

John W Eikelboom

CANADA

View details

Tabassome SIMON

Head of the department

UPMC-Paris06

FRANCE

View details

Ramzi Ajjan

Associate Professor/Consultant

University of Leeds

UNITED KINGDOM

View details

Renato Delascio Lopes

Professor

Duke University

UNITED STATES

View details

Lars Wallentin

Uppsala University

SWEDEN

View details

Thomas J. Povsic

UNITED STATES

View details

Guillaume Marquis-Gravel

Université de Montréal

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

John Alexander

Research Interests

Explore related searches

Contact this professor

Articles (20)

Counterpoint: the design and interpretation of blood transfusion randomized clinical trials

Ethical Considerations for Informed Consent in Acute Myocardial Infarction Clinical Trials

Pre-treatment lysis time of plasma-derived fibrin clots and bleeding in patients on oral anticoagulants for atrial fibrillation in the ARISTOTLE trial

Restrictive or Liberal Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: 6-Month Mortality in the MINT Trial

Relative Benefit of Dual Versus Single Antiplatelet Therapy Among Patients With Atrial Fibrillation on Oral Anticoagulation According to Time After ACS and PCI: Insights From the AUGUSTUS Trial

Effect of Four Hemoglobin Transfusion Threshold Strategies in Patients With Acute Myocardial Infarction and Anemia

Association between overweight and obesity with coronary artery bypass graft failure: an individual patient data analysis of clinical trials

The ROMA trial: 7 years of trial activities and the development of the ROMA trial network

Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial

Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation

Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation

Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary Intervention

The Effect of Posterior Pericardiotomy on the Incidence of Atrial Fibrillation After Cardiac Surgery–Extended Follow-Up study (PALACS-EF): rationale and design

Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial

Prophylactic levosimendan in patients with low ejection fraction undergoing coronary artery bypass grafting: A pooled analysis of two multicentre randomised controlled trials

Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation

Associated factors and clinical outcomes in mechanical circulatory support use in patients undergoing high risk on-pump cardiac surgery: Insights from the LEVO-CTS trial

Rationale and design of a randomized trial evaluating an external support device for saphenous vein coronary grafts

Equipoise in Clinical Trials: Enough Uncertainty in Whose Opinion?

Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex

Collaborators (16)

Alexander Fanaroff

Jeffrey Carson

Yogesh Sharma

Dean Fergusson

Sana M. Al-Khatib

Derek Chew

Philippe Gabriel Steg

Maria Brooks

Christopher B Granger

John W Eikelboom

Tabassome SIMON

Ramzi Ajjan

Renato Delascio Lopes

Lars Wallentin

Thomas J. Povsic

Guillaume Marquis-Gravel

Make your next move.